ArticleFrontiers in oncology2021

FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma.

Zheng Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.